FDA Finally Approves a Cheaper, Generic Version of the EpiPen
Gizmodo ---------- A life-saving but increasingly expensive treatment for severe allergic attacks is poised to become cheaper. On Thursday, the Food and Drug Administration announced its approval a generic version of the EpiPen and EpiPen Jr sold by pharmaceutical company Mylan. The approval comes in the wake of several scandals involving Mylan’s version, including an ongoing shortage of the drug. To learn more click on the picture below to read the article.